SIMILAR PATTERNS OF AMINO ACIDS FOR 2VN1_A_FK5A501_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | PHE A 141PHE A 153TRP A 162TYR A 185ILE A 194PHE A 202 | None | 1.18A | 2vn1A-1fd9A:17.4 | 2vn1A-1fd9A:24.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 131PHE A 141ASP A 142VAL A 158TRP A 162TYR A 185ILE A 194PHE A 202 | None | 0.75A | 2vn1A-1fd9A:17.4 | 2vn1A-1fd9A:24.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 10 | TYR A 26PHE A 36ASP A 37ARG A 42PHE A 46VAL A 55TRP A 59TYR A 82ILE A 91PHE A 99 | None | 0.60A | 2vn1A-1fkkA:19.4 | 2vn1A-1fkkA:41.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hxj | BETA-GLUCOSIDASE (Zea mays) |
PF00232(Glyco_hydro_1) | 5 | TYR A 163PHE A 151VAL A 140TRP A 96PHE A 166 | None | 1.36A | 2vn1A-1hxjA:undetectable | 2vn1A-1hxjA:15.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 6 | PHE A 102PHE A 114TRP A 123TYR A 146ILE A 155PHE A 163 | None | 1.09A | 2vn1A-1jvwA:15.8 | 2vn1A-1jvwA:28.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 8 | TYR A 92PHE A 102ARG A 108VAL A 119TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.63A | 2vn1A-1jvwA:15.8 | 2vn1A-1jvwA:28.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 8 | TYR A 92PHE A 102ASP A 103ARG A 108TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.78A | 2vn1A-1jvwA:15.8 | 2vn1A-1jvwA:28.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 6 | TYR A 57PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122 | None | 1.47A | 2vn1A-1kt1A:17.6 | 2vn1A-1kt1A:17.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 6 | TYR A 57PHE A 77VAL A 86TRP A 90TYR A 113PHE A 130 | None | 0.75A | 2vn1A-1kt1A:17.6 | 2vn1A-1kt1A:17.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n1a | FKBP52 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57PHE A 67ASP A 68PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.62A | 2vn1A-1n1aA:20.8 | 2vn1A-1n1aA:39.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 135PHE A 145ASP A 146VAL A 171TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.36A | 2vn1A-1pbkA:18.1 | 2vn1A-1pbkA:35.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | PHE A 156PHE A 168TRP A 177TYR A 200ILE A 208PHE A 216 | None | 1.36A | 2vn1A-1q6hA:16.7 | 2vn1A-1q6hA:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 9 | TYR A 146PHE A 156ASP A 157ARG A 162VAL A 173TRP A 177TYR A 200ILE A 208PHE A 216 | None | 0.66A | 2vn1A-1q6hA:16.7 | 2vn1A-1q6hA:23.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 10 | TYR A 40PHE A 50ASP A 51ARG A 56PHE A 60VAL A 69TRP A 73TYR A 96ILE A 105PHE A 113 | None | 0.77A | 2vn1A-1r9hA:22.0 | 2vn1A-1r9hA:44.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 8 | TYR A 37PHE A 47ASP A 48VAL A 66TRP A 70TYR A 99ILE A 113PHE A 121 | None | 0.64A | 2vn1A-1u79A:18.5 | 2vn1A-1u79A:41.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wdw | TRYPTOPHAN SYNTHASEBETA CHAIN 1 (Pyrococcusfuriosus) |
PF00291(PALP) | 5 | PHE B 199ARG B 205TYR B 26ILE B 195PHE B 35 | None | 1.38A | 2vn1A-1wdwB:undetectable | 2vn1A-1wdwB:16.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x3w | PEPTIDE:N-GLYCANASE (Saccharomycescerevisiae) |
PF03835(Rad4) | 5 | ASP A 242ARG A 230VAL A 212TYR A 247ILE A 246 | NoneNoneNoneNoneSUC A1002 (-4.5A) | 1.38A | 2vn1A-1x3wA:undetectable | 2vn1A-1x3wA:18.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 10 | TYR A 26PHE A 36ASP A 37ARG A 42PHE A 46VAL A 55TRP A 59TYR A 82ILE A 91PHE A 99 | FK5 A 108 ( 4.0A)FK5 A 108 ( 4.8A)FK5 A 108 ( 3.3A)FK5 A 108 (-3.7A)FK5 A 108 ( 4.0A)FK5 A 108 ( 3.4A)FK5 A 108 ( 3.6A)FK5 A 108 ( 4.7A)NoneNone | 0.29A | 2vn1A-1yatA:20.8 | 2vn1A-1yatA:38.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gh4 | PUTATIVE GLYCOSYLHYDROLASE YTER (Bacillussubtilis) |
PF07470(Glyco_hydro_88) | 5 | TYR A 285ASP A 224ARG A 52TYR A 295ILE A 226 | None | 1.23A | 2vn1A-2gh4A:undetectable | 2vn1A-2gh4A:16.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ozg | GCN5-RELATEDN-ACETYLTRANSFERASE (Trichormusvariabilis) |
PF13527(Acetyltransf_9)PF13530(SCP2_2) | 5 | TYR A 214ASP A 232ARG A 183PHE A 166VAL A 158 | None | 1.49A | 2vn1A-2ozgA:undetectable | 2vn1A-2ozgA:16.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56PHE A 66ASP A 67PHE A 76VAL A 85TRP A 89TYR A 112ILE A 121PHE A 129 | PEG A 201 (-4.4A)NoneNonePEG A 201 ( 3.9A)PEG A 201 (-3.6A)PEG A 201 (-3.7A)NoneNoneNone | 0.81A | 2vn1A-2pbcA:15.2 | 2vn1A-2pbcA:42.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r4i | UNCHARACTERIZEDPROTEIN (Cytophagahutchinsonii) |
PF14534(DUF4440) | 5 | TYR A 53PHE A 36VAL A 63TYR A 100CYH A 118 | IPA A 127 (-4.6A)IPA A 127 ( 4.1A)NoneNoneIPA A 126 ( 3.7A) | 1.34A | 2vn1A-2r4iA:undetectable | 2vn1A-2r4iA:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | PHE A 65ASP A 66VAL A 82TRP A 86PHE A 126 | RAP A 138 (-3.5A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.57A | 2vn1A-2vcdA:14.6 | 2vn1A-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55PHE A 65ASP A 66VAL A 82TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-3.5A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-2.3A) | 0.63A | 2vn1A-2vcdA:14.6 | 2vn1A-2vcdA:30.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 9 | TYR A 33PHE A 43ARG A 49PHE A 53VAL A 62TRP A 66TYR A 89ILE A 98PHE A 106 | None | 0.59A | 2vn1A-2y78A:19.2 | 2vn1A-2y78A:39.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 9 | TYR A 33PHE A 43ASP A 44ARG A 49PHE A 53TRP A 66TYR A 89ILE A 98PHE A 106 | None | 0.73A | 2vn1A-2y78A:19.2 | 2vn1A-2y78A:39.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b05 | ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE (Sulfolobusshibatae) |
PF01070(FMN_dh) | 5 | ASP A 150ARG A 114VAL A 64ILE A 191PHE A 53 | None | 1.24A | 2vn1A-3b05A:undetectable | 2vn1A-3b05A:16.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b7x | FK506-BINDINGPROTEIN 6 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 61ASP A 73TYR A 118CYH A 123ILE A 127PHE A 135 | None | 1.09A | 2vn1A-3b7xA:16.7 | 2vn1A-3b7xA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b7x | FK506-BINDINGPROTEIN 6 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 61PHE A 72ASP A 73CYH A 123ILE A 127PHE A 135 | None | 1.01A | 2vn1A-3b7xA:16.7 | 2vn1A-3b7xA:33.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3foc | TRYPTOPHANYL-TRNASYNTHETASE (Giardiaintestinalis) |
PF00579(tRNA-synt_1b) | 6 | PHE A 256ASP A 208ARG A 214PHE A 212VAL A 106TYR A 155 | None | 1.45A | 2vn1A-3focA:undetectable | 2vn1A-3focA:15.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k7d | GLUTAMATE-AMMONIA-LIGASEADENYLYLTRANSFERASE (Escherichiacoli) |
PF03710(GlnE)PF08335(GlnD_UR_UTase) | 5 | PHE A 771VAL A 788TYR A 688ILE A 705PHE A 803 | None | 1.46A | 2vn1A-3k7dA:undetectable | 2vn1A-3k7dA:13.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 67ASP A 68PHE A 77TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.88A | 2vn1A-3o5dA:20.6 | 2vn1A-3o5dA:39.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 67PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.75A | 2vn1A-3o5dA:20.6 | 2vn1A-3o5dA:39.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 67ASP A 68PHE A 77TYR A 113ILE A 122PHE A 130 | None | 0.83A | 2vn1A-3o5eA:21.2 | 2vn1A-3o5eA:46.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 67PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.85A | 2vn1A-3o5eA:21.2 | 2vn1A-3o5eA:46.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 9 | TYR A 43PHE A 54ARG A 60PHE A 64VAL A 73TRP A 77TYR A 100ILE A 109PHE A 117 | None | 0.62A | 2vn1A-3pa7A:23.8 | 2vn1A-3pa7A:80.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 9 | TYR A 43PHE A 54ASP A 55ARG A 60PHE A 64VAL A 73TRP A 77ILE A 109PHE A 117 | None | 0.75A | 2vn1A-3pa7A:23.8 | 2vn1A-3pa7A:80.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 6 | PHE A 323ASP A 324TRP A 345TYR A 368ILE A 376PHE A 384 | None | 0.82A | 2vn1A-4bf8A:17.3 | 2vn1A-4bf8A:38.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313PHE A 323ASP A 324PHE A 332VAL A 341TRP A 345PHE A 384 | None | 0.94A | 2vn1A-4bf8A:17.3 | 2vn1A-4bf8A:38.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313PHE A 323ASP A 324VAL A 341TRP A 345TYR A 368PHE A 384 | None | 0.86A | 2vn1A-4bf8A:17.3 | 2vn1A-4bf8A:38.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ckm | SAS-6 (Leishmaniamajor) |
PF16531(SAS-6_N) | 5 | TYR A 196PHE A 209VAL A 173ILE A 263PHE A 199 | None | 1.43A | 2vn1A-4ckmA:undetectable | 2vn1A-4ckmA:21.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dip | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 52PHE A 63TRP A 88ILE A 119PHE A 127 | None | 0.54A | 2vn1A-4dipA:17.9 | 2vn1A-4dipA:33.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dip | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 52TRP A 88TYR A 111ILE A 119PHE A 127 | None | 0.62A | 2vn1A-4dipA:17.9 | 2vn1A-4dipA:33.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 10 | TYR A 33PHE A 43ASP A 44ARG A 49PHE A 53VAL A 62TRP A 66TYR A 89ILE A 98PHE A 106 | FK5 A 201 ( 3.9A)FK5 A 201 (-4.8A)FK5 A 201 (-3.5A)FK5 A 201 ( 3.7A)FK5 A 201 (-4.1A)FK5 A 201 ( 3.6A)FK5 A 201 (-3.4A)FK5 A 201 (-4.7A)NoneFK5 A 201 (-4.8A) | 0.42A | 2vn1A-4dz3A:20.1 | 2vn1A-4dz3A:40.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 5 | PHE A 46VAL A 55TYR A 82ILE A 91PHE A 99 | None | 0.72A | 2vn1A-4iqcA:19.3 | 2vn1A-4iqcA:39.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 36ARG A 42PHE A 46TYR A 82ILE A 91PHE A 99 | None | 0.80A | 2vn1A-4iqcA:19.3 | 2vn1A-4iqcA:39.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 36ASP A 37ARG A 42TYR A 82ILE A 91PHE A 99 | None | 0.73A | 2vn1A-4iqcA:19.3 | 2vn1A-4iqcA:39.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57PHE A 67ARG A 73PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.87A | 2vn1A-4lawA:21.0 | 2vn1A-4lawA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57PHE A 67ASP A 68ARG A 73PHE A 77VAL A 86TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.92A | 2vn1A-4lawA:21.0 | 2vn1A-4lawA:22.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4msp | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C)PF13499(EF-hand_7) | 6 | TYR A 33PHE A 44TRP A 69TYR A 92ILE A 100PHE A 108 | None | 0.64A | 2vn1A-4mspA:18.0 | 2vn1A-4mspA:31.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56PHE A 66ASP A 67PHE A 76VAL A 85TRP A 89TYR A 112ILE A 121PHE A 129 | FK5 A 201 (-4.1A)FK5 A 201 (-4.7A)FK5 A 201 (-3.4A)FK5 A 201 (-4.0A)FK5 A 201 (-3.4A)FK5 A 201 (-3.5A)FK5 A 201 (-4.5A)NoneFK5 A 201 (-4.9A) | 0.28A | 2vn1A-4nnrA:16.1 | 2vn1A-4nnrA:38.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA (Homo sapiens;Thermusthermophilus) |
PF00254(FKBP_C) | 5 | TYR A 13ASP A 23TYR A 63ILE A 72PHE A 80 | FK5 A 201 ( 3.6A)FK5 A 201 (-3.6A)FK5 A 201 (-4.4A)NoneFK5 A 201 ( 4.8A) | 0.43A | 2vn1A-4odrA:13.1 | 2vn1A-4odrA:23.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 67ARG A 73PHE A 77VAL A 86TRP A 90TYR A 113PHE A 130 | None | 0.79A | 2vn1A-4r0xA:22.2 | 2vn1A-4r0xA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 67ASP A 68ARG A 73PHE A 77TYR A 113PHE A 130 | None | 0.86A | 2vn1A-4r0xA:22.2 | 2vn1A-4r0xA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 67ASP A 68PHE A 77TYR A 113ILE A 122PHE A 130 | None | 0.88A | 2vn1A-4r0xA:22.2 | 2vn1A-4r0xA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 67PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.76A | 2vn1A-4r0xA:22.2 | 2vn1A-4r0xA:49.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 10 | TYR C 36PHE C 55ASP C 56ARG C 61PHE C 64VAL C 73TRP C 77TYR C 100ILE C 109PHE C 117 | FK5 C 201 (-4.1A)FK5 C 201 ( 4.8A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A)NoneFK5 C 201 (-4.7A) | 0.51A | 2vn1A-5b8iC:18.4 | 2vn1A-5b8iC:36.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7p | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 26PHE A 36ASP A 37ARG A 42PHE A 46VAL A 55TRP A 59TYR A 82PHE A 146 | None | 0.65A | 2vn1A-5i7pA:17.9 | 2vn1A-5i7pA:32.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 26PHE A 36ASP A 37ARG A 42PHE A 46VAL A 55TRP A 59TYR A 82PHE A 147 | None | 0.59A | 2vn1A-5i7qA:18.2 | 2vn1A-5i7qA:32.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 7 | TYR A 30ASP A 41ARG A 46PHE A 50VAL A 59TYR A 97ILE A 102 | None | 1.38A | 2vn1A-5i98A:17.8 | 2vn1A-5i98A:33.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 10 | TYR A 30PHE A 40ASP A 41ARG A 46PHE A 50VAL A 59TRP A 63TYR A 97ILE A 106PHE A 114 | None | 0.66A | 2vn1A-5i98A:17.8 | 2vn1A-5i98A:33.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 10 | TYR A 27PHE A 37ASP A 38ARG A 43PHE A 47VAL A 56TRP A 60TYR A 83ILE A 92PHE A 100 | None | 0.76A | 2vn1A-5j6eA:19.3 | 2vn1A-5j6eA:42.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jd3 | LAE5 (unculturedbacterium) |
PF13472(Lipase_GDSL_2) | 5 | TYR A 2PHE A 208VAL A 129ILE A 11PHE A 3 | None | 1.49A | 2vn1A-5jd3A:undetectable | 2vn1A-5jd3A:17.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l1b | GLUTAMATE RECEPTOR2,GLUTAMATE RECEPTOR2 (Rattusnorvegicus) |
PF00060(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) | 5 | ASP A 138ARG A 141VAL A 205TYR A 177ILE A 168 | None | 1.35A | 2vn1A-5l1bA:undetectable | 2vn1A-5l1bA:11.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8t | UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei;Saccharomycescerevisiae) |
no annotation | 10 | TYR A 33PHE A 43ASP A 44ARG A 49PHE A 53VAL A 62TRP A 66TYR A 89ILE A 98PHE A 106 | 8ZV A 201 (-3.8A)8ZV A 201 (-4.8A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-3.3A)8ZV A 201 (-4.6A)8ZV A 201 ( 4.8A)8ZV A 201 (-4.6A) | 0.52A | 2vn1A-5v8tA:20.3 | 2vn1A-5v8tA:20.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x5y | PROBABLE ATP-BINDINGCOMPONENT OF ABCTRANSPORTER (Pseudomonasaeruginosa) |
no annotation | 5 | PHE B 165ASP B 194PHE B 46CYH B 204ILE B 203 | None | 1.45A | 2vn1A-5x5yB:undetectable | 2vn1A-5x5yB:22.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 6 | PHE A 157PHE A 166TRP A 175TYR A 198ILE A 207PHE A 215 | NoneTLA A 301 ( 4.6A)TLA A 301 (-3.4A)NoneNoneNone | 1.23A | 2vn1A-5xb0A:16.2 | 2vn1A-5xb0A:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 8 | TYR A 147PHE A 157ASP A 158VAL A 171TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)NoneTLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.87A | 2vn1A-5xb0A:16.2 | 2vn1A-5xb0A:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 8 | TYR A 38ASP A 49ARG A 54PHE A 58VAL A 67TRP A 71TYR A 94ILE A 99 | None | 1.45A | 2vn1A-6b4pA:21.3 | 2vn1A-6b4pA:43.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 10 | TYR A 38PHE A 48ASP A 49ARG A 54PHE A 58VAL A 67TRP A 71TYR A 94ILE A 103PHE A 111 | None | 0.59A | 2vn1A-6b4pA:21.3 | 2vn1A-6b4pA:43.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ba5 | INACTIVETYROSINE-PROTEINKINASE TRANSMEMBRANERECEPTOR ROR1VARIABLE DOMAINHEAVY CHAIN,ANTIBODY R11VARIABLE DOMAIN OFLIGHT CHAIN,ANTIBODY R11 (Homo sapiens) |
no annotation | 5 | TYR B 96PHE B 103ASP B 102ARG M 332VAL A 96 | None | 1.40A | 2vn1A-6ba5B:undetectable | 2vn1A-6ba5B:20.30 |